Lipid and Fat Metabolism
Lipid and Fat Metabolism
Lipid and Fat Metabolism
Lipid Metabolism
β-OXIDATION
FA ! Acetyl-CoA
• Triacylglycerols (TAGs) and glycogen are the two major forms of stored energy in vertebrates
• Glycogen can supply ATP for muscle contraction for less than an hour
• Glycogen stores depleted 12-15 h after eating and shorter if exercising
• Fats are the most highly concentrated form of stored biological energy
• Long-term
storage solution!
• Important for
migratory birds
who fly
incredibly long
distances
• Ruby-throated
hummingbird
winters in
Central America
and nests in
southern Canada – often flies non-stop! Store large amounts of TAGs
% dry-weight body fat = 70% when migration begins; 30% or less for non-migratory birds
• Sustained work is fueled by metabolism of TAGs which are very efficient energy stores
because:
(1) They are stored in an anhydrous form (no water present)
(2) Their fatty acids are more reduced than monosaccharides. Must go through many more
oxidation steps than carbohydrates before completely broken down to CO2
* Fats have 9 calories/g whereas carbohydrates have 4 calories/g (alcohol = 7 cal/g)
255
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
• Long chain fatty acids are the ideal storage fuel: hold more calories, and body has a virtually
unlimited capacity to store fat; 70 kg man with 11% body fat has over 100,000 kcal stored as fat
in abdominal cavity; only about 600 kcal in glycogen
•Fats can support body for long time: 60-90 days; obese people can survive for over a year
without food.
How is this stored energy used?
- Fatty acids released from TAGs, transported to cytoplasm and then mitochondria of
peripheral tissues (muscle cells) for degradation
- Catabolized by process called
β−oxidation
• 4 step process
• Yields Acetyl-CoA
units that feed into the
TCA cycle
- When too much fuel is around,
fatty acids are made, linked to
glycerol (TAGs are made) and
stored in adipocytes.
•LOCALIZATION OF PROCESSES:
- Degradation = mitochondrial
matrix
- Synthesis = cytosol
METABOLISM OF FATS: Adsorption and
Mobilization of Fatty Acids
256
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
257
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
1. Emulsification starts in the stomach and continues in the lumen of the small
intestine
• Starts as a big glob of hydrophobic fat – has limited surface area to attack
• In the stomach the fat is heated to liquify, peristaltic movements help emulsify (like a
washing machine) (mixer making mayonaise)
2. In the small intestine, fat particles are coated with bile salts and digested by
pancreatic lipases
• Form MICELLES
• Hydrophobic portions interact with lipids while the hydrophilic groups remain exposed to water
• Disc-like shapes - free fatty acids and bile
• Recycled through hepatic portal vein from intestine back to liver
258
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
259
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
260
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
CHYLOMICRONS
lymphatic system
thoracic duct
subclavian vein
heart
circulation
261
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
262
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
ANIMATION:
http://www.brookscole.com/chemistry_d/templates/student_resources/shared_resources/animations/carnitine/carnitine1.html
263
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
CARNITINE:
- Diet: red meat, dairy, poultry, fish
- Body: made in liver and kidneys
- Enters cells by specific transporter
- Carnitine deficiencies:
§ Symptoms:
• Poor muscle tone
• Muscle weakness
• Brain dysfunction
• Heart dysfunction
§ Primary Deficiency: Rare disorder due to faulty transporter that allows carnitine into
cells
§ Secondary Deficiency: Poor dietary intake or metabolic diseases that deplete or limit
stores
§ Treatment: Pharmaceutical administration of carnitine to supplemental stores in the
body; Can flood system and enough carnitine can enter if due to a faulty transporter
- NOTE: NO evidence exists that if normal, taking more supplements of carnitine does
anything. Not bad – excess carnitine is not harmful but not necessarily beneficial.
264
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
265
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
ANIMATION: http://www.wiley.com/college/fob/anim/
Fig. 19-9 -- The Oxidation Pathway of Fatty Acyl-CoA
266
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
SUMMARY OF THE
PRODUCTS OF EACH
CYCLE:
- Acyl-CoA which re-
enters β−oxidation
- 1 Acetyl-CoA which
enters TCA
- 1 FADH2
- 1 NADH
267
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
The balanced equation for oxidizing one palmitoyl CoA by seven cycles of β−oxidation Net yield of
ATP per palmitate oxidized to 16 CO2
ATP generated
8 acetyl CoA 80
7 FADH2 10.5
7 NADH 17.5
108 ATP
ATP expended to activate palmitate -2
Net yield: 106 ATP
268
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
protein 0.39
*e.g. C 6H12 O6 + 6 O 2 to 6 CO 2 + 6 H 20
269
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
The natural response to glucose and energy deficiency is involves two metabolic processes. Firstly the
adrenal cortex secretes glucocorticoids to stimulate gluconeogenesis. Secondly growth hormone is
secreted to accelerate lipolysis in adipose tissue to provide fatty acids for oxidation.
270
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
• Ketone Bodies:
• β-Hydroxybutyrate
• Acetoacetate
• Acetone – expelled in breath
• Ketone bodies are acids – can cause lowering of
blood pH leading to acidosis (ketosis); untreated
can lead to coma and death
271
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
from liver
from liver
1. β-Ketothiolase. The final step of the β-oxidation pathway runs backwards, condensing 2 acetyl-
CoA to produce acetoacetyl-CoA, with release of one CoA.
2. HMG-CoA Synthase catalyzes condensation of a third acetate moiety (from acetyl-CoA) with
acetoacetyl-CoA to form hydroxymethylglutaryl-CoA (HMG-CoA).
3. HMG-CoA Lyase cleaves HMG-CoA to yield acetoacetate plus acetyl-CoA.
4. β-Hydroxybutyrate Dehydrogenase catalyzes inter-conversion of the ketone bodies
acetoacetate and β-hydroxybutyrate.
Ketone Bodies Are Oxidized in Mitochondria of many tissues OTHER than liver
DIABETES:
"Starvation of cells in the midst of plenty"
• Third leading cause of death in the U.S.
– Two types: Type 1 and Type 2
• For glucose to get into cells, insulin must be present
• Causes of diabetes – Insufficient insulin is secreted or
insulin does not stimulate its target cells
• Glucose builds up in the blood, overflows into urine,
and passes out of body.
• Body loses main fuel source even though blood full of
glucose
• Consequences:
– Blood and urine [glucose] is elevated
– Glucose is abundant in blood, but uptake by
cells in muscle, liver, and adipose cells is low
272
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
273
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
- If on this type of diet, be sure to drink lots of water and supplement with vitamins and salt
- BE BALANCED! Weight loss = Eat fewer calories and increase exercise
- 1 pound of fat = 3500 calories
o Cut 500 calories/day and lose 1 pound per week
o Safe weight loss that will last = 2 pounds per week
- EVERYTHING IN MODERATION to keep body in balance – eat all food groups
274
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
275
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
276
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
EXTRA INFORMATION
DIABETES
Insulin-dependent diabetes Non-insulin dependent diabetes
mellitus mellitus
Synonym Type I Type II
Age of onset During childhood or puberty After age 35
Nutrition status at time of
Frequently undernourished Obesity
onset
Prevalence 10-20% of diagnosed diabetics 80-90% of diagnosed diabetics
Genetic predisposition Moderate Very strong
Insulin resistance; not enough Beta
Defect or deficiency Beta cells are destroyed
cells
Ketosis Common Rare
Plasma insulin Low to absent Normal to high
Acute complications Ketoacidosis Hyperosmolar coma
Oral hypoglycemia drugs Unresponsive Responsive
Treatment with insulin Always Usually not required
277
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
Type II
• Comprises > 90% of the diagnosed cases
• Affects almost 20% of individuals over age 65
• Characterized by an insensitivity to insulin (impaired recognition of insulin)
• Insulin levels are elevated, but affected individuals have low numbers of or defects in insulin
receptors
• Transport of glucose into muscle, live and adipose tissue resudes significantly and despite
abundant glucose , cells metabolically starved
• Respond by increased gluconeogenesis and catabolism of fat and protein
Insulin Resistance
Ë Complication of obesity and type 2 diabetes
¯ Mildly increased plasma glucose
¯ Normal or increased plasma insulin
° Tissue insensitivity to insulin
Ë Several levels of defects
¯ Pre-receptor: rare
° Defect: insulin receptor antibodies, abnormal molecule
¯ Receptor:
° Decreased number or affinity of insulin receptors
¯ Post-receptor : Most probable site of insulin resistance in diabetes
° Defects in intracellular signal transduction, decreased activity of key enzymes
such as pyruvate dehydrogenase or glycogen synthase
¯ Glucose transport: To be established
° Deficient or defective glucose transporters
278
CHM333 LECTURE 34 - 36: 4/19 – 22/7/13 SPRING 2013 Professor Christine Hrycyna
• Prevention:
• Maintaining ideal body weight (weight management) and an active lifestyle may prevent
the onset of type II diabetes in people at risk for the disease.
Drug Treatment:
1. Sulfonylurea drugs – enhance insulin secretion (e.g. glyburide)
2. α-glucosidase inhibitors: inhibits the digestion of ingested carbohydrates, thereby resulting in
a smaller rise in blood glucose concentration following meals. Results in delayed glucose
absorption Effect is additive to that of sulfonylureas when used in combination.
279